Clinical Trial Update: Phase2a Primaquine Dose Escalation Study [Phase 2]

View source ↗

Summary

A Phase 2a dose-escalation trial of primaquine for malaria has completed, providing early safety and dosing information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Primaquine (primaquine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria | Phase 2 | Status: COMPLETED